{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:09Z","timestamp":1740147309855,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bamlanivimab and etesevimab had been granted emergency use authorization in children under 12\u00a0years who are at risk of progression from mild\/moderate coronavirus disease 2019 to severe disease and hospitalization.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>We report on a 5-year-old\u00a0white male with preexisting conditions, predisposing him to severe disease, who developed hypoxia and flushing 3\u00a0minutes into his infusion, thus meeting the criteria for anaphylaxis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We believe this patient developed either an immunoglobulin E-mediated anaphylactic or a non-immunoglobulin E-mediated anaphylactoid reaction to bamlanivimab and etesevimab, which is an important possibility to consider on administration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03779-3","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T01:02:38Z","timestamp":1677200558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-6663","authenticated-orcid":false,"given":"Rajapillai L. I.","family":"Pillai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Szczerba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijen W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Y.","family":"Camelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Paez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"1","key":"3779_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31557\/APJCP.2021.22.1.19","volume":"22","author":"P Fadavi","year":"2021","unstructured":"Fadavi P, Houshyari M, Yousefi Kashi AS, Jarrahi AM, Roshanmehr F, Broomand MA, Sandoughdaran S, Taghizadeh-Hesary F. Review on the oncology practice in the midst of COVID-19 crisis: the challenges and solutions. Asian Pac J Cancer Prev. 2021;22(1):19\u201324.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"3779_CR2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.rpor.2020.07.001","volume":"25","author":"A Rakhsha","year":"2020","unstructured":"Rakhsha A, Azghandi S, Taghizadeh-Hesary F. COVID-19 pandemic and patients with cancer: the protocol of a Clinical Oncology Center in Tehran, Iran. Rep Pract Oncol Radiother. 2020;25(5):765\u20137.","journal-title":"Rep Pract Oncol Radiother"},{"key":"3779_CR3","unstructured":"Fact sheet for health care providers: emergency use authorization (EUA) of bamlanivimab and etesevimab. https:\/\/www.fda.gov\/media\/145802\/download."},{"issue":"7","key":"3779_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jama.2021.0202","volume":"325","author":"RL Gottlieb","year":"2021","unstructured":"Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, et\u00a0al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2021;325(7):632\u201344.","journal-title":"JAMA"},{"key":"3779_CR5","unstructured":"Eli Lilly and Company. A study of immune system proteins in participants with mild to moderate COVID-19 illness (BLAZE-4). In: https:\/\/clinicaltrials.gov; 2021."},{"key":"3779_CR6","unstructured":"Eli Lilly and Company. A study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in participants with mild to moderate COVID-19 illness (BLAZE-1). In: https:\/\/clinicaltrials.gov; 2021."},{"issue":"15","key":"3779_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","volume":"385","author":"M Dougan","year":"2021","unstructured":"Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, et\u00a0al. Bamlanivimab plus etesevimab in mild or moderate Covid-19. N Engl J Med. 2021;385(15):1382\u201392.","journal-title":"N Engl J Med"},{"key":"3779_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/08971900211048139","author":"S Nhean","year":"2021","unstructured":"Nhean S, Varela ME, Nguyen YN, Juarez A, Huynh T, Udeh D, Tseng AL. COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab\/etesevimab, and casirivimab\/imdevimab) and pharmacological considerations. J Pharm Pract. 2021. https:\/\/doi.org\/10.1177\/08971900211048139.","journal-title":"J Pharm Pract"},{"issue":"4","key":"3779_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.iac.2021.07.009","volume":"41","author":"P Poowuttikul","year":"2021","unstructured":"Poowuttikul P, Seth D. Anaphylaxis in children and adolescents. Immunol Allergy Clin N Am. 2021;41(4):627\u201338.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"2","key":"3779_CR10","first-page":"138","volume":"15","author":"V Lagopoulos","year":"2011","unstructured":"Lagopoulos V, Gigi E. Anaphylactic and anaphylactoid reactions during the perioperative period. Hippokratia. 2011;15(2):138.","journal-title":"Hippokratia"},{"issue":"4","key":"3779_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010;9(4):325\u201338.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"3779_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40629-019-00109-2","volume":"28","author":"M Worm","year":"2019","unstructured":"Worm M, Hanschmann-Mohn T, Scherer Hofmeier K, Cardona V, Turner P, D\u00f6lle-Bierke S. Drug-induced anaphylaxis\u2014elicitors, mechanisms and diagnosis. Allergo J Int. 2019;28(8):327\u20139.","journal-title":"Allergo J Int"},{"issue":"1","key":"3779_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12948-022-00167-y","volume":"20","author":"M Sobczak","year":"2022","unstructured":"Sobczak M, Pawliczak R. The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis. Clin Mol Allergy. 2022;20(1):1.","journal-title":"Clin Mol Allergy"},{"issue":"2","key":"3779_CR14","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1188\/10.CJON.E10-E21","volume":"14","author":"WH Vogel","year":"2010","unstructured":"Vogel WH. Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs. 2010;14(2):E10-21.","journal-title":"Clin J Oncol Nurs"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03779-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T01:02:48Z","timestamp":1677200568000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03779-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03779-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Reporting of the patient\u2019s case was discussed with their legal guardian who provided consent to have their case documented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant disclosures or competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}